This award congratulates the six new brain tumour centres for excellence in treatment, research and care. This is an impressive achievement as despite the challenges of the COVID-19 pandemic, these centres have been able to transform their services to elevate their wrap-around patient care.
With 12,000 people diagnosed with a brain tumour every year in the UK1, there has never been a more important time to recognise the efforts of NHS staff committed to developing and improving brain tumour treatment and care.
The committee found the Bristol Network demonstrated excellent treatment and care across the network and Bristol was recognised for its commitment to service development, in particular the further development of its rehabilitation pathways.
In addition to the excellent patient support at all stages of their treatment, the committee commended Bristol for its neuropathology services. Bristol is a leading voice in the Tessa Jowell Academy and is spearheading the effort to widen access to genomic testing across the UK.